Whitepapers

Whitepaper Jul 28, 2026

Preparing for Universal Orphan Drug JCA Submissions

Whitepaper Jul 23, 2026

Did the Rules of Pharma Market Research Change Overnight?

Whitepaper Jul 21, 2026

Stop Guessing: How to Choose and Execute the Right Validation Design for Cases, Exposures, and Outcomes in Real-World Data

Whitepaper Jul 9, 2026

Beyond Claims: Dutch and Nordic Linked Data as European References for Precision Endpoints and High Impact Real-World Decisions

Whitepaper Jun 26, 2026

Unlocking the 505(b) (2) Pathway: A Practical Guide to Success

Whitepaper Jun 9, 2026

CAR‑T in Autoimmune Disease: What’s Changing and What Comes Next

Whitepaper Apr 13, 2026

Approval isn’t the Finish Line for Breakthrough Innovations in Neuroscience

Sunset through clouds

Whitepaper Apr 2, 2026

The Medical Affairs Blueprint for Biotech

Doctors talking to pharmaceutical sales representative, presenting new pharmaceutical product. Hospital director, manager talking with doctors team.

Whitepaper Mar 16, 2026

From Transactional to Transformational: Building Mutual Value in Expert Partnerships

Whitepaper Feb 19, 2026

Integrated Evidence Generation Planning: From Strategy to Execution

Whitepaper Jan 30, 2026

Oncology Outlook for 2026

Whitepaper Dec 2, 2025

Pressure on Pharmaceutical Prices

Whitepaper Nov 19, 2025

The European Medicines Agency’s Reflection Paper on Patient Experience Data

Whitepaper Nov 5, 2025

Elevating Cross-Functional Strategic Planning in Pharma

Whitepaper Nov 5, 2025

Real-World Evidence Without Borders: Navigating Evidence Transportability in HTA and JCA Decision-Making

Whitepaper Oct 30, 2025

What Counts in Cancer Care

1 2 3 … 7